Clinical Trials Browser

Endometrial Neoplasms × prexasertib × 90 days × Clear all

NCT05548296 2026-05-14

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Phase 2 Recruiting

Endometrial Neoplasms